National Cancer Institute

Organisation

People

Eros Lazzerini Denchi
Senior Investigator28 Sept 2026ccr.cancer.gov

Trials

NCT07463807
Phase 1/2Recruiting162 people11 Mar 2026clinicaltrials.gov
NCT07444710
Phase 1Not yet recruiting16 people3 Mar 2026clinicaltrials.gov
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Phase 3Recruiting1,978 people6 Feb 2026clinicaltrials.gov
Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda
CollaboratorNo phaseNot yet recruiting300 people5 Feb 2026clinicaltrials.gov
NCT07349641
Phase 2Not yet recruiting55 people20 Jan 2026clinicaltrials.gov
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
CollaboratorPhase 2Recruiting164 people19 Dec 2025clinicaltrials.gov
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
Phase 2Recruiting108 people15 Dec 2025clinicaltrials.gov
NCT07278856
CollaboratorPhase 1Recruiting20 people12 Dec 2025clinicaltrials.gov
Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
CollaboratorNo phaseRecruiting184 people19 Nov 2025clinicaltrials.gov
NCT07220187
CollaboratorPhase 3Not yet recruiting102 people23 Oct 2025clinicaltrials.gov
NCT07218913
CollaboratorPhase 1Recruiting44 people21 Oct 2025clinicaltrials.gov
NCT07202247
CollaboratorPhase 2Recruiting60 people1 Oct 2025clinicaltrials.gov
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Phase 2Recruiting180 people29 Sept 2025clinicaltrials.gov
NCT07174570
CollaboratorPhase 2Recruiting39 people16 Sept 2025clinicaltrials.gov
NCT07162038
Phase 1Recruiting155 people9 Sept 2025clinicaltrials.gov
Family Communications After Genetic Testing
CollaboratorNo phaseRecruiting4,186 people27 Aug 2025clinicaltrials.gov
NCT07101445
CollaboratorPhase 4Recruiting94 people3 Aug 2025clinicaltrials.gov
NCT07099638
CollaboratorPhase 2Recruiting496 people1 Aug 2025clinicaltrials.gov
NCT07095517
CollaboratorPhase 1Recruiting20 people31 Jul 2025clinicaltrials.gov
NCT07085728
CollaboratorPhase 2Recruiting74 people25 Jul 2025clinicaltrials.gov

Awards made

Saros Therapeutics
US$2m2 Oct 2026prnewswire.com
Kristopher Andrew Sarosiek
Overcoming ovarian cancer chemoresistance by co-targeting senescence and apoptosisR01CA31152223 Sept 2026reporter.nih.gov
Harvard University D/b/a Harvard School of Public Health
Overcoming ovarian cancer chemoresistance by co-targeting senescence and apoptosisR01CA311522US$390.4k23 Sept 2026reporter.nih.gov

Funded papers

Autophagy Flux Is Remodeled Sex- and Cell Type-Specifically During Human Aging, and Is Linked to Reduced Physical Function in Older Adults
CA030199, OD036254, CA0141951 Oct 2026api.crossref.org
Effectiveness of an exercise intervention on cognition in breast cancer survivors: a randomized controlled trial
30 Sept 2026api.crossref.org
Exercise slows biological aging in breast cancer survivors: secondary analysis of a randomized trial
30 Sept 2026api.crossref.org
Efficacy of Tailored Messages for 28-Week Exercise Sustainability in People with HIV
P30CA01570430 Sept 2026api.crossref.org
Effect of pre-existing dementia on cancer-specific and all-cause mortality in patients with cancer in Denmark: a population-based cohort study
R00CA27758029 Sept 2026api.crossref.org
Recurrent deletions and regulatory disruption of the Y chromosome in cancer
R35CA29402228 Sept 2026api.crossref.org
Gene-Specific Analysis of Clonal Hematopoiesis Identifies the Association between ASXL1 and Lung Cancer Risk
28 Sept 2026api.crossref.org
Endogenous oestradiol concentrations and cardiovascular outcomes in healthy older women: findings from the SHOW Study
28 Sept 2026api.crossref.org
Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment
P30CA008748, P50CA247749, P50CA171963, PO1CA101937, R01CA237263, R01CA24852628 Sept 2026api.crossref.org
Uncovering hypothesis-generating associations between prescription drugs and digestive cancer risk: a case-control drug-wide association study (DWAS)
R21CA263489, P30CA00874828 Sept 2026pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma surveillance in Europe: challenges and lessons from global practice
U01CA2839353 Sept 2026pubmed.ncbi.nlm.nih.gov
The Impact of Aerobic Exercise on Circulating T-Cells and NK-Cells in Colorectal Cancer Survivors: A Secondary Analysis of a Randomized Trial
R00CA2186031 Jan 2026api.crossref.org
The development of juntas contra el virus del papiloma humano: An HPV self-sampling intervention for underscreened Latinas
P30CA006927, U54CA2217051 Jan 2026api.crossref.org

Papers

Hepatocellular carcinoma surveillance in Europe: challenges and lessons from global practice
The Lancet regional health. Europe2 Oct 2026
Tailored text messages sustain exercise in older people with HIV
AIDS and behavior1 Oct 2026
Predicting Oral Cancer From Precursor Lesions: The Case for a Standardized Framework of Analysis to Improve Prediction Modeling
Head & neck26 Sept 2026
A Circulating Proteomic Signature of Allostatic Load Is Associated with Multisystem Disease and Mortality
Proteomes24 Sept 2026
A Portable Colorimetric Biosensor Platform for Urinary Colorectal Cancer Biomarker Testing in Low-Resource Settings
Biosensors24 Sept 2026
AdaFuse: Adaptive Multimodal Fusion for Lung Cancer Risk Prediction via Reinforcement Learning
Proceedings of machine learning research23 Sept 2026
UV signature mutation hyperhotspots as genomic dosimeters
Photochemistry and photobiology23 Sept 2026
Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer
Cancer22 Sept 2026